Literature DB >> 26561305

Effects of Propofol on Excitatory and Inhibitory Amino Acid Neurotransmitter Balance in Rats with Neurogenic Pulmonary Edema Induced by Subarachnoid Hemorrhage.

Lili Zhang1, Jin Jin1, Jianyu Yao2, Ziyong Yue1, Yuting Wei1, Wanchao Yang1, Songbin Fu3, Wenzhi Li4.   

Abstract

INTRODUCTION: Propofol exhibits neuroprotective effects mediated by the inhibition of excitatory amino acid (EAA) neurotransmitter release and potentiation of inhibitory amino acid (IAA) neurotransmitters. To our knowledge, this is the first study to investigate the effects of propofol on the EAA and IAA balance in neurogenic pulmonary edema (NPE).
METHODS: Sixty male Wistar rats were randomized to Sham, NPE, Low-dose propofol, and High-dose propofol groups. NPE was induced via rapid injection of autologous blood (0.5 ml) into the cisterna magna. The Low- and High-dose propofol groups were pretreated with boluses of 2 and 5 mg kg(-1), respectively, prior to blood injection, followed by continuous propofol infusion at 6 and 15 mg kg(-1) h(-1), respectively. The mean arterial pressure (MAP), heart rate, intracranial pressure (ICP), peak inspiratory pressure (PIP), and arterial blood gases were continuously recorded. After 2 h, the lung wet-to-dry weight ratio, total protein concentration in the bronchoalveolar lavage fluid (BALF), brain water content, cortical EAA and IAA levels, chest X-ray, and histological staining of lung sections were evaluated.
RESULTS: Blood injections into the cisterna magna induced NPE and hemodynamic changes. Propofol alleviated the increases in the MAP, ICP, and PIP, improved oxygenation and histopathological changes, ameliorated pulmonary and cerebral edema, increased the IAA brain levels, and decreased the ratio of Glu to γ-aminobutyric acid.
CONCLUSIONS: The current findings suggest that propofol improves NPE likely via IAA accumulation and the regulation of EAA and IAA balance, which may represent an effective treatment for NPE.

Entities:  

Keywords:  Excitatory amino acid; Inhibitory amino acid; Neurogenic pulmonary edema; Propofol; Subarachnoid hemorrhage

Mesh:

Substances:

Year:  2016        PMID: 26561305     DOI: 10.1007/s12028-015-0206-x

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  50 in total

Review 1.  Structure and function of inhibitory glycine receptors.

Authors:  H Betz
Journal:  Q Rev Biophys       Date:  1992-11       Impact factor: 5.318

Review 2.  Molecular and cellular mechanisms of general anaesthesia.

Authors:  N P Franks; W R Lieb
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

Review 3.  Neurogenic Pulmonary Edema.

Authors:  Katharina M Busl; Thomas P Bleck
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

4.  Effects of intravenous anesthetic agents on glutamate release: a role for GABAA receptor-mediated inhibition.

Authors:  D J Buggy; B Nicol; D J Rowbotham; D G Lambert
Journal:  Anesthesiology       Date:  2000-04       Impact factor: 7.892

Review 5.  Propofol.

Authors:  C Vanlersberghe; F Camu
Journal:  Handb Exp Pharmacol       Date:  2008

6.  Facilitation of glutamate release from rat cerebral cortex nerve terminal by subanesthetic concentration propofol.

Authors:  Cheng-Wei Lu; Tzu-Yu Lin; Han-Sun Chiang; Su-Jane Wang
Journal:  Synapse       Date:  2009-09       Impact factor: 2.562

7.  Effects of propofol on nociceptive response and power spectra of electroencephalographic and systemic arterial pressure signals in the rat: correlation with plasma concentration.

Authors:  C H Yang; M H Shyr; T B Kuo; P P Tan; S H Chan
Journal:  J Pharmacol Exp Ther       Date:  1995-12       Impact factor: 4.030

8.  Role of glycine receptors and glycine release for the neuroprotective activity of bilobalide.

Authors:  Cornelia Kiewert; Vikas Kumar; Oksana Hildmann; Joachim Hartmann; Markus Hillert; Jochen Klein
Journal:  Brain Res       Date:  2008-01-31       Impact factor: 3.252

9.  Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study.

Authors:  N J Solenski; E C Haley; N F Kassell; G Kongable; T Germanson; L Truskowski; J C Torner
Journal:  Crit Care Med       Date:  1995-06       Impact factor: 7.598

10.  Behavior and cellular evidence for propofol-induced hypnosis involving brain glycine receptors.

Authors:  Hai T Nguyen; Ke-yong Li; Ralph L daGraca; Ellise Delphin; Ming Xiong; Jiang H Ye
Journal:  Anesthesiology       Date:  2009-02       Impact factor: 7.892

View more
  4 in total

1.  [Electroacupuncture protects septic rats from acute lung injury through the JAK1/STAT3 pathway].

Authors:  Cancan Xie; Shuanghua Wu; Zhengrong Li; Bing Huang; Weizhong Zeng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

2.  PVN Blockade of p44/42 MAPK Pathway Attenuates Salt-induced Hypertension through Modulating Neurotransmitters and Attenuating Oxidative Stress.

Authors:  Hong-Li Gao; Xiao-Jing Yu; Kai-Li Liu; Xiao-Lian Shi; Jie Qi; Yan-Mei Chen; Yan Zhang; Juan Bai; Qiu-Yue Yi; Zhi-Peng Feng; Wen-Sheng Chen; Wei Cui; Jin-Jun Liu; Guo-Qing Zhu; Yu-Ming Kang
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

3.  Argon reduces the pulmonary vascular tone in rats and humans by GABA-receptor activation.

Authors:  Said Suleiman; Sergej Klassen; Ira Katz; Galina Balakirski; Julia Krabbe; Saskia von Stillfried; Svetlana Kintsler; Till Braunschweig; Aaron Babendreyer; Jan Spillner; Sebastian Kalverkamp; Thomas Schröder; Manfred Moeller; Mark Coburn; Stefan Uhlig; Christian Martin; Annette D Rieg
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

4.  Oral CoQ10 attenuates high salt-induced hypertension by restoring neurotransmitters and cytokines in the hypothalamic paraventricular nucleus.

Authors:  Hong-Li Gao; Xiao-Jing Yu; Jie Qi; Qiu-Yue Yi; Wang-Hui Jing; Wen-Yan Sun; Wei Cui; Jian-Jun Mu; Zu-Yi Yuan; Xiu-Fang Zhao; Kai-Li Liu; Guo-Qing Zhu; Xiao-Lian Shi; Jin-Jun Liu; Yu-Ming Kang
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.